WELL Health Provides Preliminary Patient Visits for Q3-2022 Reflecting Strong Growth and Enhanced Revenue Outlook

• WELL expects¹ to announce strong financial results for Q3-2022 with another record for omni-channel patient visits and interactions which will lead to another record revenue performance.
• Total omni-channel patient visits² in Q3-2022 increased by approximately 53% when compared to Q3-2021. The Company also achieved an annualized run-rate of ~5.0 million patient interactions.
• WELL continues to successfully allocate capital and complete highly accretive tuck-in acquisitions in both Canada and the US.  Today it completed the acquisition of various Canadian EMR, Billing and Clinical assets from CloudMD Software & Services Inc. ("CloudMD").
• WELL will disclose its financial results and host its Q3-2022 earnings conference call on Thursday November 10, 2022.

VANCOUVER, BC, Nov. 2, 2022 /PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to provide a preview of the volume of its patient visit and interactions in Q3-2022. 

WELL expects¹ to report strong financial results underpinned by significant growth in patient visits. WELL achieved a total of 892,966 omni-channel patient visits² in Q3-2022, representing a year-over-year increase of 53% compared to Q3-2021, and a 7% increase compared to Q2-2022. In addition, MyHealth conducted 169,294 diagnostic visits in Q3-2022, while Wisp completed 186,952 asynchronous patient consultations. Combining WELL's omni-channel patient visits², MyHealth's diagnostic visits and Wisp's asynchronous patient consultations, WELL achieved a total of 1,249,212 patient interactions in Q3-2022, representing an annualized run-rate of 5.0 million patient interactions.  

"We're very pleased to report another record quarter of patient visits and interactions mainly delivered by our more than 2,300 healthcare provider partners systemwide," said Hamed Shahbazi, Chairman and CEO of WELL. "WELL's business model is simple and effective because it is laser focused on supporting and tech-enabling the healthcare providers that form the bedrock of our healthcare ecosystem.  Our solutions help care providers with all aspects of their business including front and back-office solutions so that they can focus on patient care and not administrative burdens and deliver improved patient outcomes.  Healthcare workers continue to face significant challenges as we transition to a post-pandemic world, and WELL is applying all its talents and resources to support them.  WELL's business not only continues to reflect the strength and resilience associated with the healthcare industry, but we've also demonstrated that when care providers are supported well, their practices flourish. Our industry leading organic growth is showing our model of 'caring for the car providers' is working."

Eva Fong, CFO of WELL, commented, "Our strong Q3 patient visits and interactions were driven by healthy growth in our US-based virtual services businesses, Circle Medical and Wisp, which now exceed an annual revenue run-rate of US$100M on a combined basis, reflecting 124% YoY organic growth and are operating profitably on an Adjusted EBITDA³ basis.  In addition, Q3 patient visits and interaction metrics were positively impacted by the onboarding of new practitioners onto our platform and the closing of the Inliv acquisition.  We look forward to reporting Q3 results."   

WELL is pleased to announce that it has closed the previously announced acquisition of various Canadian EMR, billing and clinical assets from CloudMD for approximately $5.7 million paid in cash, subject to post-closing adjustments and holdbacks.  WELL reaffirms its expectation that the assets will operate profitably while contributing more than $9M in topline revenues. This transaction reflects WELL's disciplined capital allocation strategy and continued expansion in the Canadian healthcare service and healthcare IT space.  Integration of the newly acquired assets will begin immediately.   

WELL will release its Third Quarter 2022 financial results for the period ended September 30, 2022, on Thursday, November 10, 2022.  The Company will hold a conference call and simultaneous webcast to discuss its results on the same day at 1:00 pm EST (10:00 am PST).  The call will be hosted by Hamed Shahbazi, Chairman and Chief Executive Officer and Eva Fong, Chief Financial Officer.  Please dial in 10 minutes prior to the start of the call.

Per: "Hamed Shahbazi"            
Hamed Shahbazi
Chief Executive Officer, Chairman and Director         

WELL is a practitioner focused digital healthcare company whose overarching objective is to positively impact health outcomes to empower and support healthcare practitioners and their patients. WELL has built an innovative practitioner enablement platform that includes comprehensive end to end practice management tools inclusive of virtual care and digital patient engagement capabilities as well as Electronic Medical Records (EMR), Revenue Cycle Management (RCM) and data protection services. WELL uses this platform to power healthcare practitioners both inside and outside of WELL's own omni-channel patient services offerings. As such, WELL owns and operates Canada's largest network of outpatient medical clinics serving primary and specialized healthcare services and is the provider of a leading multi-national, multi-disciplinary telehealth offering. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL" and on OTCQX under the symbol "WHTCF". To learn more about the Company, please visit: www.well.company.

This news release may contain "Forward-Looking Information" within the meaning of applicable Canadian securities laws, including without limitation WELL's expectations to report strong financial results.  Forward-Looking Information is based upon several estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties, and contingencies.  Forward-Looking Information generally can be identified by the use of forward-looking words such as "may", "should", "will", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations.  Forward-looking Information involves known and unknown risks, uncertainties and other factors that may cause future results, performance, or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by such Forward Looking Information and, which are not guarantees of future performance.  WELL's statements expressed or implied by Forward Looking Information are subject to several risks, uncertainties, and conditions, many of which are outside of WELL 's control, and undue reliance should not be placed on such statements.  Forward-Looking Information is qualified in their entirety by inherent risks and uncertainties, including: direct and indirect material adverse effects from the COVID-19 pandemic; adverse market conditions; risks inherent in the primary healthcare sector in general; regulatory and legislative changes; that future results may vary from historical results; inability to obtain any requisite future financing on suitable terms; any inability to realize the expected benefits and synergies of acquisitions; that market competition may affect the business, results and financial condition of WELL and other risk factors identified in documents filed by WELL under its profile at www.sedar.com, including its most recent Annual Information Form.  Except as required by securities law, WELL does not assume any obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise.

SOURCE WELL Health Technologies Corp.